mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.087 |
0.1 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.079 |
0.1 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.1 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.1 |